Você procurou por: lymphoblastic (Inglês - Maltês)

blincyto is used to treat adults with acute lymphoblastic leukaemia.
blincyto jintuża biex jittratta adulti b’lewkimja limfoblastika akuta.

• a type of leukaemia, called t-cell acute lymphoblastic leukaemia.
• tip ta 'lewkemja, msejħa lewkemja limfoblastika akuta taċ- ċellula t.

philadelphia chromosome positive acute lymphoblastic leukaemia (ph-positive all).
lewkimja limfoblastika akuta posittiva għall-kromosoma ta’ filadelfja (ph-posittiva all).

acute lymphoblastic leukaemia is caused by abnormal growth of some types of white blood cells.
lewkimja akuta limfoblastika hi kkawżata minn żvilupp anormali ta’ xi tipi ta’ ċelluli bojod tad- demm.

xaluprine is used for acute lymphoblastic leukaemia (also called acute lymphocytic leukaemia or all).
xaluprine jintuża fil-lewkimja limfoblastika akuta (msejħa wkoll lewkimja limfoċitika akuta jew all).

in studies conducted in mice, growth and metastasis of melanoma and lymphoblastic leukaemia tumour cells was not increased by the administration of natalizumab.
fi studji mwettqa fil-ġrieden, ma kienx hemm żjieda fit-tkabbir u l-metastasi taċ-ċelluli tat-tumur ta’ melanoma u lewkimja limfoblastika minħabba l-għotja ta’ natalizumab.

in this case, its cells called lymphoblasts. • a type of lymphoma, called t-cell lymphoblastic lymphoma.
f' dan il- każ, iċ- ċelluli tagħha jissejħu limfoblasti. • tip ta 'limfoma, tissejjaħ limfoma limfoblastika akuta taċ- ċellula t.

in contrast to normal cells, lymphoblastic tumour cells have a very limited capacity for synthesising asparagine because of a significantly reduced expression of asparagine synthetase.
b’kuntrast ma’ ċelluli normali, iċ- ċelluli limfoblastiċi tat-tumur għandhom kapaċità limitata ħafna biex jissintetizzaw lil asparagine minħabba espressjoni mnaqqsa b’mod sinifikanti ta’ asparagine synthetase.

acute lymphoblastic leukaemia is a form of leukaemia in which certain abnormal white cells (named lymphoblasts) start growing out of control.
lewkimja limfoblastika akuta hija forma ta' lewkimja li fiha ċerti ċelluli bojod anormali (magħrufin bħala limfoblasti) li jibdew jikbru mingħajr kontroll.

adult and paediatric patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy.
pazjenti adulti u pedjatriċi li jkunu għadhom kif ġew dijanjostikati posittivi għall-lewkimja limfoblastika akuta b’kromosoma ta’ filadelfja (ph+ all) integrata b’kimoterapija.

antiviral activity in vitro: the in vitro antiviral activity of lopinavir against laboratory and clinical hiv strains was evaluated in acutely infected lymphoblastic cell lines and peripheral blood lymphocytes, respectively.
pazjenti novizzi ingħataw inibituri nucleoside reverse transcriptase.

acute lymphoblastic leukaemia is a cancer of the blood in which a particular kind of white blood cell called “b- lymphocyte” is growing out of control.
il-lewkimja limfoblastika akuta hi kanċer tad-demm li fih tip partikolari ta’ ċellula tad-demm bajda msejħa “limfoċite b” tibda tikber bla kontroll.

treatment of acute lymphoblastic leukaemia (all) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and where there is no other treatment option anticipated to result in a durable response.
it- trattament ta ’ lewkimja akuta limfoblastika (all) f' pazjenti pedjatriċi li rkadew jew huma refrattarji wara li ngħataw qabel ta 'l- anqas żewġ reġimeni u fejn ma hemm l- ebda għażla għal trattament ieħor li kien antiċipat li jwassal għal rispons dewwiem.

the compound selectively inhibits proliferation and induces apoptosis in bcr-abl positive cell lines as well as fresh leukaemic cells from philadelphia chromosome positive cml and acute lymphoblastic leukaemia (all) patients.
din is-sutanza tinpedixxi b’mod selettiv il- proliferazzjoni u tistimola apoptożi f’linji ta’ ċelluli li jkunu pożittivi għal bcr-abl kif ukoll f’ċelluli lewkimiċi friski li jinstabu f’pazjenti li jkollhom cml li tkun pożittiva għall-kromosoma ta’ filadelfja u f’pazjenti b’acute lymphoblastic leukaemia (all).

the in vitro antiviral activity of amprenavir was evaluated against hiv-1 iiib in both acutely and chronically infected lymphoblastic cell lines (mt-4, cem-ccrf, h9) and in peripheral blood lymphocytes.
l-attività antivirali in vitro ta’ amprenavir ġiet valutata ma’ l-hiv-1 iiib f’razzez ta’ ċelluli limfoblastiċi infettati b’mod akut u b’mod kroniku (mt-4, cem-ccrf,h9) u f’limfoċiti periferali tad-demm.